Genetic predisposition (NLRP3 V198M mutation) for IL-1-mediated inflammation in a patient with Schnitzler syndrome.
Jan
J
Loock
Peter
P
Lamprecht
Christian
C
Timmann
Ulrich
U
Mrowietz
Elena
E
Csernok
Wolfgang L
WL
Gross
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001483:Base Sequence; D002352:Carrier Proteins / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D006801:Humans; D007249:Inflammation / Q000235:genetics / Q000276:immunology; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D053583:Interleukin-1beta / Q000276:immunology*; D008875:Middle Aged; D000071199:NLR Family, Pyrin Domain-Containing 3 Protein; D019873:Schnitzler Syndrome / Q000188:drug therapy / Q000235:genetics* / Q000503:physiopathology
D018501:Antirheumatic Agents; D002352:Carrier Proteins; D053590:Interleukin 1 Receptor Antagonist Protein; D053583:Interleukin-1beta; D000071199:NLR Family, Pyrin Domain-Containing 3 Protein; C453881:NLRP3 protein, human